Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87
FreeObituary

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

September 13, 2024
Vol.50 No.34
By Paul Goldberg
Clinical Roundup

DNA methylation contributes to 9/11-related breast cancers

September 13, 2024
Vol.50 No.34
Clinical Roundup

Mechanisms that clear mutations drive field cancerization in mammary tissue

September 13, 2024
Vol.50 No.34
In Brief

NCI funds a $3.7M effort to develop AI that predicts breast cancer risk while addressing health disparities

September 06, 2024
Vol.50 No.33
Why Bernie Fisher deserves a biography (and why I am writing it)
Cancer History ProjectFree

Why Bernie Fisher deserves a biography (and why I am writing it)

August 09, 2024
Vol.50 No.32
By Stacy Wentworth
In Brief

Richard Bleicher named chief of new Division of Breast Surgery at Fox Chase

August 09, 2024
Vol.50 No.32
In Brief

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

August 02, 2024
Vol.50 No.31
Clinical Roundup

Electronic prompt for surgeons may reduce breast cancer overtreatment

July 19, 2024
Vol.50 No.29
In Brief

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

July 12, 2024
Vol.50 No.28
Clinical Roundup

Chemotherapy disrupts gut microbiome in patients with breast cancer

July 12, 2024
Vol.50 No.28

Posts navigation

Previous1…121314…33Next

Trending Stories

  • Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
    PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.”
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
  • Most Favored Nation drug pricing could put China on top
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
    A kit for at-home unsupervised self-collection clears FDA finish line

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account